VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer
187,133MODERNA
33,878JANSSEN
2,321PFIZER\BIONTECH
1,091GLAXOSMITHKLINE BIOLOGICALS
983UNKNOWN MANUFACTURER
363MERCK & CO. INC.
229SEQIRUS, INC.
45DYNAVAX TECHNOLOGIES CORPORATION
41NOVARTIS VACCINES AND DIAGNOSTICS
29SANOFI PASTEUR
18EMERGENT BIOSOLUTIONS
8PAXVAX
7TEVA PHARMACEUTICALS
4PFIZER\WYETH
3BERNA BIOTECH, LTD.
2SMITHKLINE BEECHAM
2INTERCELL AG
2PROTEIN SCIENCES CORPORATION
1CSL LIMITED

Incidents per State

State Total
77,548
AK1,869
AL5,581
AR3,688
AS47
AZ14,288
CA61,984
CO11,665
CT8,149
DC1,663
DE1,807
FL37,749
FM5
GA15,058
GU120
HI2,453
IA4,625
ID2,692
IL20,334
IN24,007
KS4,615
KY7,696
LA4,887
MA14,654
MD12,514
ME3,129
MH11
MI18,739
MN12,528
MO9,710
MP29
MS2,790
MT2,375
NC16,368
ND1,356
NE2,880
NH3,100
NJ17,634
NM3,916
NV4,239
NY34,355
OH19,081
OK6,195
OR8,636
PA23,083
PR2,370
QM2
RI2,088
SC6,411
SD1,212
TN9,131
TX35,174
UT4,273
VA14,937
VI64
VT1,676
WA14,909
WI11,259
WV2,388
WY861
XB5
XL1
XV2

ID: 1534228
Sex: F
Age:
State: CO

Vax Date: 02/03/2021
Onset Date: 02/10/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Heart palpitations/ palpitations on exertion; Shortness of breath; unusual feeling in relation to heart/chest area; This is a spontaneous report from a contactable other healthcare professional (patient). A 32-year-old female patient received BNT162B2, via an unspecified route of administration on 03Feb2021 (Batch/Lot Number: EN5318) at the age of 32 years old as dose 2, single for COVID-19 immunization. Patient was not pregnant at the time of vaccination. The patient's medical history was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. No allergies to medications, food, or other products. Concomitant medication(s) included acyclovir [aciclovir] taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of BNT162B2 (Batch/Lot Number: EK4176) on 13Jan2021 at the age of 32 years old for COVID-19 immunization. Heart palpitations began one week after second dose. On 10Feb2021, the patient experienced Shortness of breath and palpitations on exertion. Currently pending cardiology work up. Also, continuing to have unusual feeling in relation to heart/chest area (10Feb2021). Adverse events resulted in Doctor or other healthcare professional office/clinic visit. Treatment received included Medications, EKG, bloodwork, cardiology referral. Outcome of events were not recovered.

Other Meds: ACYCLOVIR [ACICLOVIR]

Current Illness:

ID: 1534229
Sex: F
Age:
State: NY

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Dizziness; Vomiting; Metallic taste; Tingly mouth; Difficulty swallowing; Rapid heartbeat; Flushed red face; Flushed red face; This is a spontaneous report from a contactable consumer (patient). This 38-year-old female patient received dose 1 of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EW0150) via an unspecified route of administration on 07Apr2021 at 14:00 (at the age of 38-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history penicillin allergy and artificial food dye allergy. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to the vaccine. Concomitant medications included a multivitamin. The patient previously received vancomycin from an unknown date and experienced allergy. On 07Apr2021 at 14:15 the patient experienced dizziness, vomiting, metallic taste, tingly mouth, difficulty swallowing, rapid heartbeat, and flushed red face. The patient visited an emergency room/department or urgent care as a result of the events. The patient received treatment with diphenhydramine (BENADRYL), famotidine (PEPCID), cetirizine (ZYRTEC), dexamethasone (DECADRON), and albuterol. The outcomes of dizziness, vomiting, metallic taste, tingly mouth, difficulty swallowing, rapid heartbeat, and flushed red face were recovering. It was also reported that since the vaccination the patient had not been tested for COVID-19. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1534230
Sex: F
Age:
State: NH

Vax Date: 03/28/2021
Onset Date: 03/28/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Forehead and cheekbone area went numb, then left arm (opposite of shot site) and hand/fingers and front part of my left chest had intense numbing feeling.; Waves of spaciness; Weakness; Light intermittent thumb numbing/tingling; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: ER8733) via an unspecified route of administration in the right arm on 28Mar2021 at 09:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included ongoing undiagnosed one sided angioedema which was in remission for years and cervical spine degeneration (c5, c6). The patient's history of known allergies was reported as unknown. The patient did not receive any concomitant medications withing two weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021 at 10:00, reportedly 28 mins after receiving shot, her forehead and cheekbone area went numb, then left arm (opposite of shot site) and hand/fingers and front part of her left chest had intense numbing feeling. That lasted 15 mins and subsided. Then subsequently throughout the day, she would have waves of "spaciness", weakness, reoccurring every 15 or so mins. Then again that afternoon, left arm went numb, hand as well, and back side this time. A little less intense than the first one, on a scale of 1-10, the first one was 10 and this one was 8. Also this time, patient right arm below elbow had these sensations, but a much lower intensity...a 2-3 range. Light intermittent thumb numbing/tingling continued throughout the day. On an unknown date in 2021, the patient underwent Magnetic Resonance Imaging (MRI) of the brain, Electrocardiography (EKG) and blood tests and the results were unknown. The event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness: Angio-edema (Undiagnosed one sided angio edema)

ID: 1534231
Sex: F
Age:
State: NC

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: top of tongue got all chopped like when she had allergic reaction to nicotine; Also start having a little pain in left ovary.; Not a painful, not a shape pain, but it feels like tooth ache; lips are red; I have a fever, 100; injection site hurts; throat was swollen; lower legs got numb/her left side became numb, whole left side became numb; tongue got swollen; This is a spontaneous report from a contactable consumer (patient). A 59-year-old non-pregnant female patient received bnt162b2 (BNT162B2, Lot number was not reported), via an unspecified route of administration, administered in right arm on 08Apr2021 13:30 (at the age of 59-year-old) as dose number unknown, single for COVID-19 immunization. Medical history included asthma, bronchitis and allergy to shellfish, exotic fruit, Dust, Pet Dander, wine. Concomitant medication in which the patient received within 2 weeks of vaccination included loratadine, pseudoephedrine sulfate (CLARITIN D 12 HOUR). The patient previously took nicotine and experienced allergies. After shot (on 08Apr2021) for 20 minutes the patient stayed at the clinic. About 40 minutes later (on 08Apr2021 at 14:30) her lower legs got numb. Her tongue got swollen. By the time she came home around 14:50 her throat was swollen. She can still breath. Then, she administered Epipen. After the epipen, her left side became numb, whole left side became numb. Slowly her tongue, her throat became less swollen. She started to feel her left fingers, toes, left side face. It took 4 hours for her to feel normal. Then 22:38 her tongue was swollen, her throat felt like when she had bronchitis, her lips were red as if she had a fever, 100, injection site hurts. She can still breath. Then it gets better, tongue get less swollen, throat feels better. Then these symptoms repeated throughout the night. Also, on unspecified date her top of tongue got all chopped like when she had allergic reaction to nicotine. She also started having a little pain in left ovary on unspecified date. Not a painful, not a shape pain, but it feels like tooth ache on unspecified date. The adverse events result in Doctor or other healthcare professional office/clinic visit. Treatment was received for the reported adverse events. The outcome of the events was not recovered. Information on the lot/batch number has been requested.

Other Meds: CLARITIN D 12 HOUR

Current Illness:

ID: 1534232
Sex: F
Age:
State: CT

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Moderate pain, pain increased severity to 8/10 (Pain on entire arm and hand); Arm and hand are slightly swollen; Barely able to sleep due to pain; Felt like my entire arm and hand were having an arthritic flare, were blown up; Hand was cold to touch; palm looked red-blue; This is a spontaneous report received from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot: EW0151), via an unspecified route of administration in the left arm on 08Apr2021 at 10:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies to latex, intravenous contrast, soft shell crab, various medications, bee stings; as well as seasonal allergies, arthritis, increased blood pressure, lipidemia, chronic pain related to several injuries. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included colecalciferol (VIT D), atorvastatin calcium (ATORVASTIN), buproprion, varenicline tartrate (CHANTIX), mirabegron (MYRBETRIQ). The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot: EN6199) in the left arm on 17Mar2021 at 10:30 for COVID-19 immunisation. The patient did not receive any other vaccinations within 4 weeks. On 08Apr2021 at 15:00, several hours after injection, the patient experienced moderate pain to the entire arm and hand which increased in severity to 8/10. There was no response to ice, paracetamol (TYLENOL). The pain was so severe that the patient took tramadol to help diminish the pain. The arm and hand were slightly swollen. The patient was barely able to sleep due to the pain. It felt like the entire arm and hand were having an arthritic flare, were blown up. The hand was cold to the touch, the palm looked red-blue. Since the vaccination, the patient was not tested for COVID-19. The clinical outcome of the events was not resolved.

Other Meds: VIT D; ATORVASTIN; BUPROPION; CHANTIX; MYRBETRIQ

Current Illness:

ID: 1534233
Sex: F
Age:
State: NY

Vax Date: 03/20/2021
Onset Date:
Rec V Date: 08/07/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Rash; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 20Mar2021 at 02:45 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, asthma and allergy. The patient received other medicines (unspecified) within two weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced rash. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event rash was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534234
Sex: M
Age:
State: NC

Vax Date: 04/01/2021
Onset Date: 04/02/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Moderate fever, joint aches, chills, body aches, headache. all but the fever were severe and i was in bed aprox. 24 hrs.; Moderate fever, joint aches, chills, body aches, headache. all but the fever were severe and i was in bed aprox. 24 hrs.; Moderate fever, joint aches, chills, body aches, headache. all but the fever were severe and i was in bed aprox. 24 hrs.; Moderate fever, joint aches, chills, body aches, headache. all but the fever were severe and i was in bed aprox. 24 hrs.; Moderate fever, joint aches, chills, body aches, headache. all but the fever were severe and i was in bed aprox. 24 hrs.; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 01Apr2021 at 13:30 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. The patients medical history was reported as no. The patient had no known allergies to food, medicine or other products. The patient had taken other medications (unspecified) within two weeks prior to vaccination. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 11Mar2021 at 13:30 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 02:30, the patient experienced moderate fever, joint aches, chills, body aches, headache. All but the fever were severe and the patient was in bed approximately 24 hours. No therapeutic measures were taken as a result of the events. The clinical outcome of the events moderate fever, joint aches, chills, body aches, headache, all but the fever were severe and patient was in bed approximately 24 hours was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534235
Sex: F
Age:
State: NY

Vax Date: 03/17/2021
Onset Date: 04/05/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: pox-like lesion on thigh, observed many more lesions on mainly on midriff, but also behind knee, a couple on the arm and lesions are raised, but not itchy or painful; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) in the left arm on 17Mar2021 at 10:15 (at the age of 51-year-old) as a single dose for COVID-19 immunisation and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) on 07Apr2021 at 10:45 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included Hashimoto's disease. The patient did not have allergies to medications, food, or other products. Concomitant medications included sertraline hydrochloride (ZOLOFT) and levothyroxine (MANUFACTURER UNKNOWN) all from unknown date, for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 the patient experienced pox-like lesion on thigh and on 08Apr2021 approx. 24 hours after second vaccine dose, the patient observed many more lesions on mainly on midriff, but also behind knee, a couple on the arm and lesions are raised, but not itchy or painful. It was unknown whether therapeutic measures were taken as a result of the event. The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event pox-like lesion on thigh, observed many more lesions on mainly on midriff, but also behind knee, a couple on the arm and lesions are raised, but not itchy or painful was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ZOLOFT; LEVOTHYROXINE

Current Illness:

ID: 1534236
Sex: M
Age:
State: NM

Vax Date: 04/08/2021
Onset Date: 04/09/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Shortness of breath about 18 hours alter; Inflammation; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 08Apr2021 at 10:45 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, hypogonadism and hypothyroidism. Patient did not report any known allergies to food, medications or other products. Concomitant medications included metformin hydrochloride (METFORM), hydrochlorothiazide, lisinopril (LISINOPRIL/HCTZ), levothyroxine (MANUFACTURER UNKNOWN) and testosterone (MANUFACTURER UNKNOWN); all from unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG204) via an unspecified route of administration in the left arm on an unknown date in Mar2021 at 11:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 09Apr2021 at 08:45, the patient experienced shortness of breath about 18 hours alter and at 06:00, experienced inflammation. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events shortness of breath about 18 hours alter and inflammation were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: METFORM; LISINOPRIL/HCTZ; LEVOTHYROXINE; TESTOSTERONE

Current Illness:

ID: 1534237
Sex: M
Age:
State: NY

Vax Date: 04/01/2021
Onset Date: 04/03/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Hives and rashes 48 hours after shot. Itching. One Benadryl taken, resolved within 10-15 minutes; Hives and rashes 48 hours after shot. Itching. One Benadryl taken, resolved within 10-15 minutes; Hives and rashes 48 hours after shot. Itching. One Benadryl taken, resolved within 10-15 minutes; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8730) via an unspecified route of administration in the right arm on 01Apr2021 at 15:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included arthritis. The patient had no known allergies to food, medicine or other products. The patient had not taken other medications within two weeks prior to vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 17:00, the patient experienced hives and rashes 48 hours after shot and itching. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of hives, rashes and itching which included treatment with one Benadryl and it resolved within 10-15 minutes. The clinical outcome of the events hives and rashes 48 hours after shot and itching was resolved within 10-15 minutes after taking one Benadryl on 03Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534238
Sex: F
Age:
State: MS

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Chills; ever (highest noted was 102); nausea; vomiting; severe body aches; muscle cramps; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 06Apr2021 at 11:00(at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies to melons, certain nuts and seasonal allergies. Concomitant medications included levocabastine hydrochloride (ZYRTEC) and fluticasone propionate (FLONASE); both for unspecified indication and unknown start date. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the right arm on 16Mar2021 at 08:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 06Apr2021 at 21:00, the patient experienced chills, fever (highest noted was 102), nausea, vomiting, severe body aches & muscle cramps, fatigue. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 06Apr2021, the patient underwent body temperature and the result was 102(unit unknown). The clinical outcome of the event chills, fever (highest noted was 102), nausea, vomiting, severe body aches & muscle cramps, fatigue were recovering. No follow-up attempts are needed. No further information is expected.

Other Meds: Zyrtec; Flonase

Current Illness:

ID: 1534239
Sex: F
Age:
State: MN

Vax Date: 04/08/2021
Onset Date: 04/09/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Very tiny bit of a sore arm the next day; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 08Apr2021 at 12:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high (reported as high blood pressure), hypothyroidism and cholesterol high. The patient had no known allergies to food, medicine or other products. The patient had received other medication (unspecified) within two weeks prior to vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced very tiny bit of a sore arm the next day on 09Apr2021. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event very tiny bit of a sore arm the next day was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534240
Sex: F
Age:
State: FL

Vax Date: 04/06/2021
Onset Date: 04/08/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Rash on torso both front and back as well as upper thighs and arms; Redness at the injection site; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8732) via an unspecified route of administration in the right arm on 06Apr2021 at 10:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included angina, poor kidney function and sinus bradycardia. The patient had no known allergies. Concomitant medications included bupropion (MANUFACTURER UNKNOWN), simvastatin (MANUFACTURER UNKNOWN), paracetamol (TYLENOL), acetylsalicylic acid (ASPIRIN) etc. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 09:00, two days after receiving the vaccine, the patient developed rash on her torso both front and back as well as upper thighs and arms and redness at the injection site as well. The events resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of rash on torso both front and back as well as upper thighs and arm and redness at the injection site and included treatment diphenhydramine (MANUFACTURER UNKNOWN), famotidine (MANUFACTURER UNKNOWN) and prednisone (MANUFACTURER UNKNOWN). The clinical outcome of the events rash on torso both front and back as well as upper thighs and arm and redness at the injection site were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: BUPROPIONE; SIMVASTATIN; TYLENOL; Aspirin

Current Illness:

ID: 1534241
Sex: F
Age:
State: NY

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: The eczema on my upper back and shoulders broke out in hives after two hours of receiving the vaccine. The next morning, my skin had sharp small pains where the hives were.; The eczema on my upper back and shoulders broke out in hives after two hours of receiving the vaccine. The next morning, my skin had sharp small pains where the hives were.; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 08Apr2021 at 19:00 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 and eczema. The patient did not receive any medication within two weeks prior to vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The eczema on the patients upper back and shoulders broke out in hives on 08Apr2021 at 21:00, after two hours of receiving the vaccine. The next morning on 09Apr2021, her skin had sharp small pains where the hives were. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The patient underwent tests and investigations which included COVID-19 test on 05Apr2021, and the result was negative. The clinical outcome of the events the eczema on upper back and shoulders broke out in hives after two hours of receiving the vaccine; the next morning, skin had sharp small pains where the hives were was not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1534242
Sex: F
Age:
State: CA

Vax Date: 04/07/2021
Onset Date: 04/08/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: lightheaded; hitting her face against the wall; passed out; losing vision; was not able to sit up without losing vision, hearing; Could not stand up; sweats; nausea; This is a spontaneous report from a contactable physician (patient). A 47-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in arm right on 07Apr2021 (at the age of 47 years) (Batch/Lot Number: EW0158) as a single dose for COVID-19 immunization. Patient was not pregnant at the time of vaccination. Medical history included systemic lupus erythematosus and allergies: sulfa. Concomitant medications (other medications in two weeks) included unspecified birth control pills, allergy pills, and joint pills. The patient previously took codeine and experienced allergies. On 08Apr2021 23:00, thirty hours after the vaccination, patient got up to get something from the bathroom. She felt lightheaded - like when standing up too fast. On the way out of the bathroom, she passed out, hitting her face against the wall. When she came around, she could not stand up, had cold sweats and nausea. Symptoms lasted for several hours. She was not able to sit up without losing vision, hearing and feeling lightheaded. Patient is recovering from the events. No treatment was received. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Patient has not been tested for COVID-19 since the vaccination.; Sender's Comments: Based on the information available a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported events passed out, temporary vision loss, deafness transitory . The case will be reassessed once new information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate

Other Meds:

Current Illness:

ID: 1534243
Sex: F
Age:
State: OR

Vax Date: 03/19/2021
Onset Date: 03/20/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: rendered me immobile for two solid weeks; Severe Back pain and spasms; Severe Back pain and spasms; Right knee swollen and sore; Right knee swollen and sore; Shoulder, clavicle pain; Shoulder/clavicle pain; trapezius pain; \This is a spontaneous report from a contactable consumer (patient) who reported for herself. This non-pregnant 55-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) dose 1 via an unspecified route of administration, administered in the left arm on 19Mar2021 at 14:30 (Lot Number: ER2613) at the age of 55 years, as DOSE 1, SINGLE for COVID-19 immunization. Medical history included knee replacement, hidradenitis suppurativa, interstitial cystitis, irritable bowel syndrome, gastritis, plantar fasciitis, and arthritis. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication taken within two weeks of vaccination included mirabegron (MYRBETRIQ) 25 mb ER tabs) famotidine (PEPCID) 20 mg 1. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took Percocet, Sulfonamides and Reglan and experienced Stomach pain. The patient reported at on 20Mar2021 at 15:00, she experienced severe back pain and spasms; right knee swollen and sore; shoulder/ clavicle, and trapezius pain. She reported that the back pain and spasms were the worst she'd ever experienced and lasted 8 days. Shoulder/Clavicle pain was severe. The shoulder/clavicle pain was severe and lasted 18 days. The knee swelling/pain/stiffness lasted 16 days. The back, clavicle/shoulder pain she experienced was excruciating and rendered her immobile for two solid weeks. She stated "I will not be taking the second vaccination". She reported that she saw her Spine Doctor on 25Mar21 and she confirmed this was an adverse reaction and prescribed muscle relaxers for the spasms. The clinical outcome of "rendered me immobile for two solid weeks and trapezius pain was reported as recovering. The clinical outcome of severe back pain and spasms, right knee swollen and sore, shoulder/ clavicle, was reported as recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds: MYRBETRIQ; PEPCID [FAMOTIDINE]

Current Illness:

ID: 1534244
Sex: M
Age:
State: HI

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Worst asthma attack in decades.; Difficulty breathing.; Wheeze.; This is a spontaneous report from a contactable consumer (patient). This 67-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number ER8732) via an unspecified route of administration in the left arm on 05Apr2021 at 08:30 (at 67-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing. Prior to vaccination the patient was not diagnosed with COVID-19 and had not received any vaccines in the 4 weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received ibuprofen from an unknown date for an unknown indication and experienced allergy; and previously received the first dose of BNT162B2 (lot number EN6708) in the left arm on 15Mar2021 at 08:00 (at 67-years-old) for COVID-19 immunisation. On 05Apr2021 at 17:00 the patient experienced the worst asthma attack in decades, difficulty breathing, and wheezing. The events required a doctor's appointment and albuterol. The clinical outcomes of the events were not recovered. Since vaccination the patient had not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 1534245
Sex: F
Age:
State: MA

Vax Date: 04/03/2021
Onset Date: 04/04/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Achy; Tired; Chills; Had pain in by left arm pit nearbreast and lymph nodes; Pain in lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Apr2021 at 14:15 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient was not allergic to medications, food, or other products. Concomitant medications included vitamin d nos (VITAMIN D), HEALTH CONCERNS NASAL CAPS and multivitamin (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 14:15, 24 hours after receiving shot, the patient started to feel achy, tired, got the chills, pain in left arm pit near breast and lymph nodes. All the symptoms went away within 2 or 3 days. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. Therapeutic measures were not taken as a result of the event. The clinical outcome of the events felt achy, tired, got the chills and had pain in by left arm pit near breast and lymph nodes were recovered on an unknown date in Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: Vitamin d

Current Illness:

ID: 1534246
Sex: M
Age:
State: NY

Vax Date: 03/02/2021
Onset Date: 03/01/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: burst blood vessel in my right eye.; This is a spontaneous report received from a contactable consumer, the patient. A 53-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot: 3248), via an unspecified route of administration in the right arm on 02Mar2021 at 13:45 (at the age of 53-years-old) and the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot: 3248), via an unspecified route of administration in the right arm on 23Mar2021 at 13:30 (at the age of 53-years-old), as a single dose for COVID-19 immunisation. Medical history included allergies to penicillin. Prior to vaccination, the patient did not test positive for COVID-19. Concomitant medications included atorvastatin, multivitamins, ibuprofen (ADVIL), paracetamol (TYLENOL), melatonin (MELATON). There were no other vaccinations within 4 weeks of the COVID-19 vaccine. On an unspecified date (Mar2021), about 2 weeks after each dose, the patient experienced a burst blood vessel in the right eye. The clinical course was follows: About 2 weeks after each dose, the patient noticed a burst blood vessel in the right eye. He did not associate it with the vaccine after dose 1. It went away within 3-4 days. But it happened again approximately 2 weeks after the second dose, on 07Apr2021. Again, the patient initially did not associate it given the time lag. But today, the patient started wondering and so reported it as a precaution. There was no pain or irritation in the eye but just a red splotch on the eyeball. The patient had never had a burst blood vessel in the eye before. There was no treatment received for the event. Since the vaccination, the patient was not tested for COVID-19. The clinical outcome of the event was resolving.

Other Meds: ATORVASTATIN; TYLENOL; MELATON; ADVIL [IBUPROFEN]; MULTIVITAMINS [VITAMINS NOS]

Current Illness:

ID: 1534247
Sex: F
Age:
State: NJ

Vax Date: 04/05/2021
Onset Date: 04/05/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Extreme dizziness; Extreme chills; Overall muscle pain; Joint pain; Bone pain; Extreme fatigue; Extreme site pain; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the right arm on 05Apr2021 at 12:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure that was controlled by meds (medications). The patient had no known allergies to medications, food or other products. Concomitant medications included medications for high blood pressure, amlodipine (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN), escitalopram oxalate (LEXAPRO) and estradiol (MANUFACTURER UNKNOWN); from unknown dates for unspecified indications. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the right arm on 14Mar2021 at 15:45 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 05Apr2021 at 18:00, with in six hours the patient experienced extreme site pain. On05Apr2021 at 19:00, the patient experienced extreme chills, overall muscle pain, joint pain, bone pain and extreme fatigue. On 09Apr2021, the patient experienced extreme dizziness which set in after 4 days and continued. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events extreme site pain was resolved by 48 hours on 07Apr2021 at 18:00. The clinical outcome of the event's extreme chills, overall muscle pain, joint pain, bone pain and extreme fatigue was resolved by 48 hours on 07Apr2021 at 19:00. The clinical outcome of the event extreme dizziness was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: AMLODIPINE; HYDROCHLOROTHIAZIDE; LEXAPRO; ESTRADIOL

Current Illness:

ID: 1534248
Sex: M
Age:
State: WI

Vax Date: 04/07/2021
Onset Date: 04/09/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Severe lower back pain; "muscle spasms and tightness"; "muscle spasms and tightness"; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ewo158) via an unspecified route of administration in the right arm on 07Apr2021 at 14:15 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. The patient received unspecified medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 05:00, the patient experienced severe lower back pain with muscle spasms and tightness. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. The clinical outcome of the events severe lower back pain with "muscle spasms and tightness" were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534249
Sex: F
Age:
State: AZ

Vax Date: 02/06/2021
Onset Date: 02/06/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: hematoma; Pain in arm; Pain has increased since then in my upper arm muscle; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL 9263) via an unspecified route of administration in the arm left on 06Feb2021 at 15:30 (at the age of 70-year-old) as a single dose for COVID-19 immunisation. Medical history included thyroidectomy, hormone replacement therapy, sulfonamide allergy, seafood allergy (scallops) and fruit allergy (strawberries). The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included levothyroxine sodium (SYNTHROID) from an unknown date and unknown if ongoing for an unknown indication. The patient was allergic to amoxicillin and epinephrine. On 06Feb2021, the patient experienced pain in the arm and pain has increased since then in my upper arm muscle which would make it worse while exercising. On 10Feb2021, 4 days after the vaccination, the patient developed a hematoma. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events pain in the arm, hematoma and upper arm muscle pain were not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: SYNTHROID

Current Illness:

ID: 1534250
Sex: F
Age:
State: NC

Vax Date: 04/05/2021
Onset Date: 04/09/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Intense vertigo, followed by nausea, and vomiting and defecation. This happened three times upon awakening.; Intense vertigo, followed by nausea, and vomiting and defecation. This happened three times upon awakening.; Intense vertigo, followed by nausea, and vomiting and defecation. This happened three times upon awakening.; Intense vertigo, followed by nausea, and vomiting and defecation. This happened three times upon awakening.; This is a spontaneous report from a contactable consumer, the patient. A 73-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 15:30 (age at vaccination unknown) as a single dose for COVID-19 immunisation. The patient previously had penicillin and experienced penicillin allergy. The patient did not receive any medication within two weeks prior to vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6207) via an unspecified route of administration in the left arm on 15Mar2021 at 15:30 (age at vaccination unknown) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, the patient experienced intense vertigo, followed by nausea, and vomiting and defecation. This had happened three times upon awakening. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of intense vertigo, followed by nausea, and vomiting and defecation and included rest, and being stationary. The clinical outcome of the events intense vertigo, followed by nausea, and vomiting and defecation was unknown at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1534251
Sex: F
Age:
State: NJ

Vax Date: 04/08/2021
Onset Date: 04/09/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Pain at injection site that woke me up from sleep; Pain at injection site that woke me upfrom sleep; Mild headaches; Mild low fever; Fatigue; This is a spontaneous report from a contactable consumer (patient). A 25-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in the left arm on 08Apr2021 at 19:15 (Lot Number: EW0158), at the age of 25-years-old, as a single dose for COVID-19 immunisation. Patient was not pregnant at the time of vaccination. The patient did not have any relevant medical history (none). The patient had no known allergies with food, medication or other product. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 09Apr2021 at 04:30, the patient experienced pain at injection site that woke up her from sleep (sleep disturbed), mild headaches, mild low fever and fatigue. No therapeutic measures were taken as a result of the reported events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcomes of the events pain at injection site that woke up from sleep (sleep disturbed), mild headaches, mild low fever and fatigue were recovering, at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534252
Sex: M
Age:
State: MI

Vax Date: 03/25/2021
Onset Date: 04/02/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Difficulty breathing; Chest pains; Severe joint pain in my thumbs, shoulders, knees and ankles; painful, itchy full body rash, starting on my feet and lower legs, which then spread upward.; Rash has worsened; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021 at 16:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included history of asthma and fish allergy. Concomitant medications included vitamin d nos (VITAMIN D), ascorbic acid (VITAMIN C) and zinc (MANUFACTURER UNKNOWN); all from an unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 03Mar2021 at 17:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 02Apr2021 at 18:00, approximately one week after the second dose, severe joint pain in my thumbs, shoulders, knees and ankles. After the onset of joint pain, the patient also experienced painful itchy full body rash, starting on feet and lower legs, which then spread upward. On 07Apr2021 the patient experienced difficulty breathing and chest pains and went to the emergency room (ER). The breathing issue had subsided but the rash had worsened and the joint pain had remained over the last week. Therapeutic measures were taken as a result of adverse events which included treatment with prednisone (MANUFACTURER UNKNOWN) and antihistamines. The events difficulty breathing and chest pains resulted in emergency room/department or urgent care. On 07Apr2021, the patient underwent lab test which included PCR and Rapid (Nasal swab) and the results were negative. The clinical outcome of the events rash has worsened, severe joint pain in my thumbs, shoulders, knees and ankles, painful itchy full body rash, starting on feet and lower legs, which then spread upward, difficulty breathing and chest pains were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: Vitamin d; Vitamin c; ZINC

Current Illness:

ID: 1534253
Sex: F
Age:
State:

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: menstrual cycle started about 2-3 days early; This is a spontaneous report from a non-contactable consumer (patient). A 39-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 09Apr2021 at 14:45 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Patient was not pregnant at the time of vaccination. Patient had no relevant medical history (none). The patient had not reported any other health issues. The patient had no known allergies to medications, food or other products. The patient did not take any concomitant medications. The patient previously received first dose of BNT162B2 (Lot Number: unknown) via an unspecified route of administration on unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 09Apr2021 at 20:00, the patient had her menstrual cycle started about 2 to 3 days early. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. The clinical outcome of event (menstrual cycle started about 2-3 days early) was recovered on unknown date in Apr2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1534254
Sex: F
Age:
State: TN

Vax Date: 04/02/2021
Onset Date: 04/08/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Enlarged supraclavicular lymph node 5 days after receiving the vaccine, very painful and growing each day; Enlarged supraclavicular lymph node 5 days after receiving the vaccine, very painful and growing each day; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 02Apr2021 at 10:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included cystitis interstitial, insomnia and known allergies to strawberries. Concomitant medications included trazodone (MANUFACTURER UNKNOWN), montelukast sodium (MONTELUKAST) and daily multivitamin (MANUFACTURER UNKNOWN), all from an unknown date for an unknown indication. On an unknown date, the patient received rifampin (MANUFACTURER UNKNOWN) and bactrim (MANUFACTURER UNKNOWN) and experienced allergies for both. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 08Apr2021 at 16:30, 5 days after the vaccine, the patient experienced enlarged supraclavicular lymph node, very painful and growing each day. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of reported events which included treatment with possible antibiotics, chest X-ray and blood work on an unknown date in Apr2021. On an unknown date in Apr2021, post vaccination, the patient underwent COVID-19 test and the result was negative. The clinical outcome of enlarged supraclavicular lymph node which was very painful and growing each day was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: TRAZODONE; MONTELUKAST

Current Illness:

ID: 1534255
Sex: F
Age:
State: WA

Vax Date: 04/07/2021
Onset Date: 04/08/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Woke up with full body ache; Headache; Chills; A temp of 100.By 11:00am fever was up to 103.1, Fever went down around10pm, and was at 100.2 at 8am the following morning, which is today.; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729), via an unspecified route of administration in the right arm on 07Apr2021 at 13:00 (at the age of 43-years-old), as a single dose for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease. The patient did not have any allergies to medications, food, or other products. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN), tiotropium bromide monohydrate (SPIRIVA) and formoterol fumarate (SYMBICORT); all from unknown dates for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613), via an unspecified route of administration in the right arm on 17Mar2021 at 13:00 (at the age of 43-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 07:00, the patient woke up with full body ache, headache, chills and a temp of 100. By 11:00 fever was up to 103.1, pulse was steady at 115 beats per minute (bpm), and at one point the patient's blood o2 level was down to 91% and fever went down around 22:00. On 09Apr2021 at 08:00, the following morning, the fever was at 100.2. At the time of reporting symptoms were improving, just a headache lingered. Therapeutic measures were not taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 08Apr2021 at 07:00, the patient underwent lab test and procedure which included body temperature and result was shown as 100, on the same day at 11:00, the body temperature was shown as 103.1. On 08Apr2021, the patient underwent lab test and procedure which included pulse rate, blood o2 level and results were shown as 115 bpm and 91% respectively. On 09Apr2021 at 08:00, the patient underwent lab test and procedure which included body temperature and result was shown as 100.2. The clinical outcome of the events full body ache, headache, chills and fever were resolving at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds: GABAPENTIN; SPIRIVA; SYMBICORT

Current Illness:

ID: 1534256
Sex: F
Age:
State: NJ

Vax Date: 04/02/2021
Onset Date: 04/02/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Leg cramps; Knees and back hurting; Lightheaded with headache; Knees and back hurting; Lightheaded with headache; Nausea; This is a spontaneous report from a non-contactable consumer, the patient. A non-pregnant female patient of an unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 02Apr2021 at 12:00, as a single dose for COVID-19 immunisation. Medical history included blood pressure high. Patient had no known allergies. Concomitant medications included diphenhydramine hydrochloride (ALLERGAN), and acetylsalicylic acid (BABY ASPIRIN) from an unknown date for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 16:00, the patient experienced leg cramps, knees and back hurting, lightheaded with headache, nausea. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events leg cramps, knees and back hurting, lightheaded with headache, nausea was resolving. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: ALLERGAN; BABY ASPIRIN

Current Illness:

ID: 1534257
Sex: F
Age:
State: NE

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: hives; swollen injection site; fever; chills; muscle tension; muscle spasms; nausea; headache; metallic taste in mouth; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 10:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis. Concomitant medications included venlafaxine hydrochloride (VENLAFAXINE) and omeprazole (MANUFACTURER UNKNOWN); both for an unknown indication from an unknown date, unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Mar2021 at 10:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 08Apr2021 at 23:30, 13hours post vaccination, the patient experienced hives, swollen injection site, fever, chills, muscle tension and spasms, nausea, headache and metallic taste in mouth. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events of hives, swollen injection site, fever, chills, muscle tension and spasms, nausea, headache and metallic taste in mouth were recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: VENLAFAXINE; OMEPRAZOLE

Current Illness:

ID: 1534258
Sex: F
Age:
State: TN

Vax Date: 04/06/2021
Onset Date: 04/06/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Swollen joints are most likely agout flare-up from the vaccine'singredients.; swollen joints; hot flashes due to fever; body aches and soreness; various degrees of fever; headache; chills; achy joints, mostly concentrated on the left side of the body - fingers, elbow, knee, ankle and foot.; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6207) via an unspecified route of administration in the left arm on 06Apr2021 at 10:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high, cholesterol high, gout, body mass index high (high bmi). The patient previously received niacin (MANUFACTURER UNKNOWN) and vitamin D (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced drug allergy. The patient received other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6205) via an unspecified route of administration in the left arm on 16Mar2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021 at 16:00 after the second dose of COVID-19 vaccine, the patient experienced various degrees of fever, body aches and soreness, headache, chills and hot flashes due to fever, swollen and achy joints, mostly concentrated on the left side of the body - fingers, elbow, knee, ankle and foot. Swollen joints were most likely a gout flare-up from the vaccine's ingredients. It was unknown whether therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events various degrees of fever, body aches and soreness, headache, chills and hot flashes due to fever, swollen and achy joints, swollen joints and gout flare-up were not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1534259
Sex: F
Age:
State: NY

Vax Date: 04/02/2021
Onset Date: 04/03/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: I cant use my right hand, weak wrist ,fingers doesnt work, feel numbnesssometimes mostly in a hand, fewtimes felt higher in an arm, sometimesfeel numbness in my face, aroundeyes; felt right arm was coldcomparing with left, primary caredoctors impression - paresthesia afterreceiving vaccine.; I cant use my right hand, weak wrist ,fingers doesnt work,; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP 7533 (not sure)) via an unspecified route of administration in the right arm on 02Apr2021 at 09:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Patient had no allergies to food, medications or other products. Patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 03Apr2021, the patient stated that she could not use her right hand, weak wrist, fingers did not work, felt numbness sometimes mostly in a hand, few times felt higher in an arm, sometimes felt numbness in face, around eyes. Felt right arm was cold comparing with left, primary care doctor's impression paraesthesia after receiving vaccine. Patient was referred to neurologist. Patient will be seeing neurologist at the end of the month. Patient next vaccine shot was scheduled at May 1st and was very concern to take vaccine. The patient did not receive any treatment for the events. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events numbness, could not use her right hand, weak wrist, fingers did not work, felt numbness sometimes mostly in a hand, few times felt higher in an arm, sometimes felt numbness in face, around eyes and paraesthesia were not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1534260
Sex: F
Age:
State: OH

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Very slight feeling of numbness or pressure in a small area of my face near my mouth; Very slight feeling of numbness or pressure in a small are of my face near my mouth; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 09Apr2021 at 14:15 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, fibromyalgia, migraine, environmental allergy, anxiety, asthma, hyperlipidemia, blood pressure high, pre-diabetes, neuralgia, neuropathy and anemia. The patient received other medications within two weeks of vaccination, names were unspecified. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 19Mar2021 at 14:15 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 15:00 the patient experienced very slight feeling of numbness or pressure in a small area of face near her mouth. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event very slight feeling of numbness or pressure in a small area of face near her mouth was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534261
Sex: F
Age:
State: OH

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: An uncomfortable feeling in the back of throat; "Within a few hours my arm is terribly sore arm"; "by the end of the night I felt slight nausea"; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 10:45 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included renal failure, high blood pressure , PTSD, depression, asthma, anxiety, GERDS, kidney cancer (left kidney removed) and COVID-19. The patient had known allergies to penicillin and cephalosporins. Concomitant medications included buspirone hydrochloride (BUSPIRONE), amlodipine (MANUFACTURER UNKNOWN), norethisterone (NORLYDA), apixaban (ELIQUIS), lurasidone hydrochloride (LATUDA) and other unspecified drug; all from unknown dates for unknown indications. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Apr2021 at 11:00, after the patient first got the shot, the patient experienced an uncomfortable feeling in the back of the throat, within a few hours her arm was terribly sore and by the end of the night she felt slight nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events an uncomfortable feeling in the back of the throat, within a few hours her arm was terribly sore and by the end of the night felt slight nausea was resolved on an unknown date in Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: BUSPIRONE; AMLODIPINE; NORLYDA; ELIQUIS; LATUDA

Current Illness:

ID: 1534262
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Sore arm after injection; This is a spontaneous report from a non-contactable consumer, the patient. A unspecified aged male patient received, an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew 0153) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On an unknown date the patient experienced sore arm after injection. The clinical outcome of the event sore arm after injection was unknown at the time of this report. No follow up attempts are possible; No further information is expected.

Other Meds:

Current Illness:

ID: 1534263
Sex: M
Age:
State: CA

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Fatigue; Fever; Muscle aches; Headache; Inappropriate schedule of vaccine administered; This is a spontaneous report from a non-contactable consumer, the patient. A 48-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737), via an unspecified route of administration in the left arm on 08Apr2021 at 14:15 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. Medical history included kidney stones, cholecystectomy and elevated cholesterol. Concomitant medications included omega-3-acid ethyl ester (OMEGA-3 ETHYL ESTERS), ergocalciferol (VITAMIN D2) and dopamine hydrochloride (MEGADOSE); all from unknown dates for unspecified indications. The patient patient previously took dilaudid on unknown date for an unspecified indication and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613), via an unspecified route of administration in the left arm on 22Mar2021 at 16:45 (at the age of 48-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 14:15, onset at 24 hours post dose 2, the patient experienced fatigue then fever then muscle aches and then headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the reported events and included treatment with tylenol pm. The clinical outcome of the events fatigue, fever, muscle aches and headache were not recovered at the time of reporting. No follow-up attempts are possible. No further information is expected.

Other Meds: VITAMIN D2; MEGADOSE; Omega-3 Ethyl Esters

Current Illness:

ID: 1534264
Sex: F
Age:
State:

Vax Date: 04/01/2021
Onset Date: 04/09/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: swollen lymph node near collar bone; This is a spontaneous report from a non-contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 01Apr2021 at 13:45 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, the patient experienced swollen lymph node near collar bone on the side she got vaccinated. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event swollen lymph node near collar bone was not resolved at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1534265
Sex: F
Age:
State: NC

Vax Date: 04/02/2021
Onset Date: 04/06/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Severe throat and body ache; Severe throat and body ache; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 02Apr2021(at the age of 35-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included loratadine (CLARITIN), ascorbic acid, cyanocobalamin, ergocalciferol, nicotinamide, pyridoxine hydrochloride, retinol, riboflavin, thiamine mononitrate (ONE-A-DAY) and ibuprofen (MANUFACTURER UNKNOWN) from an unknown date for unspecified indication. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021, four days after the vaccination, the patient experienced severe throat ache and body ache and lasting longer than one week. On 09Apr2021, the patient underwent COVID-19 test (Nasal Swab) and the result was Negative. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the reported event. The clinical outcome of the events severe throat ache and body ache were not resolved. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: Claritin; One-a-day; IBUPROFEN

Current Illness:

ID: 1534266
Sex: F
Age:
State: SC

Vax Date: 03/06/2021
Onset Date: 03/19/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Injection site became inflamed; still have the spot on my arm and it is still itchy at times but has reduced to more of a discoloration of skin.; Injection site became inflamed and itchy; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Mar2021 at 13:30 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history included bipolar disorder, tree nuts allergy and allergy to bell peppers and poppy seeds. Concomitant medications included sertraline hydrochloride (ZOLOFT) and lamotrigine (LAMICTAL) both from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021, the patient had to get a tuberculosis (TB) test for work and the test came back as a false positive. The test was taken two weeks after the COVID vaccine. The patient never had a reaction to the tuberculosis (TB) test as severe. The injection site became inflamed and itchy. To rule out TB, the patient obtained a chest X-ray that proved that she did not have TB. The patient still had the spot on her arm and it was still itchy at times but has reduced to more of a discoloration of skin. Therapeutic measures were not taken as a result of the events. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events injection site became inflamed and itchy and discoloration of skin was recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ZOLOFT; LAMICTAL

Current Illness:

ID: 1534267
Sex: F
Age:
State: NJ

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: It felt the flu x2; After my first dose about 3 to Four hours after I got a severe migraine; diarrhea; fever; body ache; body was just craving anykind of juice I got very thirsty; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09Apr2021 at 13:45(at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included meningioma, stent in head, hypertension, rheumatoid, osteoporosis and disc degradation. The patient had unspecified allergies to medications, food, or other products. The patient received unspecified medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Apr2021 at 16:45 the patient experienced, after three to four hours of first dose, severe migraine, diarrhea, fever, body aches and could not got out of bed. It felt the flu x2 and the body was just craving any kind of juice as felt very thirsty. Had seen some of these side effects on the website but did not see some of the ones that what the patient had experienced. And it was known that quite a few people that have had the same. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event severe migraine, diarrhea, fever, body aches, felt flu, could not get out of bed and thirsty were recovering at the time of this report. No follow up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1534268
Sex: F
Age:
State: NJ

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533), via an unspecified route of administration in the left arm on 07Apr2021 at 15:45 (at the age of 55-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no known allergies to medications, food or other products. Concomitant medications included vitamins (LOVEWELLNESS), from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206), via an unspecified route of administration in the left arm on 16Mar2021 at 15:30 (at the age of 55-year-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 17:45, the patient experienced pain at injection site after 2 hours of vaccine. On 08Apr2021 at 07:45, after 16 hours of vaccine, the patient experienced aches in joints, felt tired and run down, nasal congestion, headache and chills. The adverse events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the events pain at injection site, aches in joints, felt tired and run down, nasal congestion, headache and chills were resolved on an unspecified date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534269
Sex: F
Age:
State: MD

Vax Date: 04/06/2021
Onset Date: 04/08/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Morbilliform rash appeared on legs; "rash had spread to trunk and arms"; "Temperature 97.7 F"; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0153) via an unspecified route of administration in the right arm on 06Apr2021 at 13:15 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension controlled with medications. The patient had no known allergies. Concomitant medications were reported as "yes prescribed medications". The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534) via an unspecified route of administration in the right arm on 15Mar2021 at 13:45 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 06:30, approximately 30 hours after second dose of vaccine, the patient experienced morbilliform rash appeared on legs approximately. On 08Apr2021 at 06:30, the patient had the "rash had spread to trunk and arms" and "temperature 97.7 F", no itching or discomfort. As of 10Apr2021 at 07:30, rash persists and temperature remains normal (97.7 F) and there was no itching or discomfort. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events morbilliform rash appeared on legs, "rash had spread to trunk and arms" and the event "temperature 97.7 F" were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534270
Sex: F
Age:
State: GA

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Burning sensation within 10 minutes of taking shot.; Muscle soreness within 10 minutes of taking shot; Prolonged and extended extreme tiredness; Tingling; Crawling sensation in skin that is ongoing since shot.; Menstrual cycle although completedweeks prior restarted within a day ofshot and continued for 2 weeks withheavy bleeding; Developed canker sore in mouth; Developed fever blister; Pain tingling in hands and feet; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 25Mar2021 at 14:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not receive any concomitant medications. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 14:15, the patient experienced burning sensation and muscle soreness within 10 minutes of taking shot, prolonged and extended extreme tiredness, tingling and crawling sensation in skin that was ongoing since shot, menstrual cycle although completed weeks prior restarted within a day of shot and continued for 2 weeks with heavy bleeding. Developed canker sore in mouth, developed fever blister, pain tingling in hands and feet. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcomes of the events burning sensation and muscle soreness within 10 minutes of taking shot, prolonged and extended extreme tiredness, tingling and crawling sensation in skin, menstrual cycle although completed weeks prior restarted within a day of shot and continued for 2 weeks with heavy bleeding, developed canker sore in mouth, developed fever blister, pain tingling in hands and feet was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534271
Sex: M
Age:
State: MI

Vax Date: 03/21/2021
Onset Date: 03/25/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Testicle soreness; Scrotum swelling; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the right arm on 21Mar2021 at 00:00 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma and supraventricular arrhythmia. The patient did not take any concomitant medication. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 12:00, the patient experienced testicle soreness and scrotum swelling. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the events testicle soreness and scrotum swelling was recovered on an unknown date. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1534272
Sex: F
Age:
State: OH

Vax Date: 03/29/2021
Onset Date: 04/05/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: "Delayed menstruation. I have a prettyregular cycle, and I am now 6 dayslate on my period"; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the arm left on 29Mar2021 at 12:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included none. Concomitant medications included loratadine (CLARITIN) and ibuprofen (ADVIL), Prenatal vitamins ; all from unknown dates for unspecified indication. The patient previously took Fluconazole and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, the patient experienced delayed menstruation. She had a pretty regular cycle, and she was six days late on her period. She had taken two negative pregnancy tests. The patient was planning to try to get pregnant later this spring, but now she was very concerned the shot will negatively impact her fertility and menstruation cycle. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event delayed menstruation was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: Claritin; Advil

Current Illness:

ID: 1534273
Sex: F
Age:
State: MI

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Right eyelid is a bit red and puffy; Right eyelid is a bit red and puffy; Slightly blurred vision; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the arm left on 07Apr2021 at 16:45(at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, migraine, allergy, chronic pain and penicillin allergy. Concomitant medications included tramadol (MANUFACTURER UNKNOWN), levothyroxine sodium (SYNTHROID), tizanidine (MANUFACTURER UNKNOWN) and trazodone (MANUFACTURER UNKNOWN) for unknown indications and from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the arm left on 17Mar2021 at 16:30 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 17:15, the patient experienced slightly blurred vision and on 09Apr2021, Saturday the patient's right eyelid was a bit red and puffy. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with fexofenadine (ALLEGRA) and a cold compress which seemed to gave some relief. The clinical outcome of the events slightly blurred vision, right eyelid was a bit red and puffy were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: TRAMADOL; SYNTHROID; TIZANIDINE; TRAZODONE

Current Illness:

ID: 1534274
Sex: M
Age:
State: NC

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Tingly face with some puffiness; Tingly face with some puffiness; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the arm right on 09Apr2021 at 10:45(at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history included high BP, high cholesterol and hypothyroidism. Concomitant medications included olmesartan medoxomil (BENICAR), levothyroxine sodium (SYNTHYROID) and rosuvastatin calcium (CRESTOR) for unknown indication and from an unknown date. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 11:00, the patient experienced tingly face with some puffiness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event tingly face with some puffiness was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: BENICAR; SYNTHYROID; CRESTOR

Current Illness:

ID: 1534275
Sex: M
Age:
State: MI

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Red rash across arms, legs and belly; Terrible diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 11:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity and borderline hypoglycemia. The patient had no known allergies to medications, food, or other products. Concomitant medications included naproxen (NAPROSYN) for an unknow indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 08Apr2021 at 23:30, about 12 hours after the vaccine, the patient experienced terrible diarrhea which lasted for several hours. On 09Apr2021, the patient had a red rash across his arms, legs and belly. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events red rash across arms, legs and belly and terrible diarrhea was resolving at the time of this report. No follow-up attempts are needed; information about lot number cannot be obtained. No further information is expected.

Other Meds: Naprosyn

Current Illness:

ID: 1534276
Sex: F
Age:
State: FL

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Headache; "Day 1-6 was mildly tired"/ "I was hit with extreme exhaustion"; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the leg left on 30Mar2021 at 08:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant past medical history. The patient had no known allergies to food, medications or other products. Concomitant medications included escitalopram oxalate (LEXAPRO), pyridoxine hydrochloride, tocopherol, folic acid, thiamine, nicotinic acid, riboflavin, calcium, selenium, cimicifuga racemose extract, magnolia officinalis, vitamin b12 nos, boron, glycine max extract (ESTROVEN) and linoleic acid (CLA); all from unknown dates for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021, "day 1-6, the patient was mildly tired". She was hit with extreme exhaustion and headache started 7 days to day 17 post injection (as reported). She missed work and could not function for half the day. It was an exhaustion she had never experienced before and could not "push" through and overcome. The patient did not receive any treatment for the events. The adverse events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 08Apr2021, the patient underwent lab tests and procedures which included nasal swab test and the result was negative. The clinical outcome of the event "Day 1-6 was mildly tired"/ "I was hit with extreme exhaustion and headache was resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected

Other Meds: LEXAPRO; ESTROVEN; Cla

Current Illness:

ID: 1534277
Sex: M
Age:
State: FL

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Fever - 102.4 F; Moderate fatigue; Severe headache; Moderate chills; Moderate muscle pain; Moderate joint pain; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EZ8729), via an unspecified route of administration in the left arm on 09Apr2021 at 09:15 (at the age of 58-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none and the patient did not have a history of allergies to any food or medications or other products. The patient did not receive any other medications within two weeks of vaccination. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201), via an unspecified route of administration in the left arm on 12Mar2021 at 10:15 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 21:00, the patient experienced fever - 102.4 degrees Fahrenheit(F), moderate fatigue, severe headache, moderate chills, moderate muscle pain and moderate joint pain. The patient underwent lab test and procedures which included body temperature test on 09Apr2021 and the result was 102.4 F. No therapeutic measures were taken for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever - 102.4 F, moderate fatigue, severe headache, moderate chills, moderate muscle pain and moderate joint pain was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 636,615

Page last modified: 03 October 2021 5:28pm